Thorn Group (TGA) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Neutral

just now

Is 4DMedical (ASX:4DX) Still Undervalued After Its TGA Approval?

Highlights 4DMedical receives Australian regulatory approval for its CT:VQ lung imaging software. The approval supports commercial expansion using existing hospital CT infrastructure. Artificial intelligence and advanced medical imaging continue driving innovation across the healthcare sector. 4DMedical Ltd (ASX:4DX) has attracted renewed market attention after securing Therapeutic Goods Administration (TGA) approval for its CT:VQ lung imaging software, an imp...

Google News

Neutral

just now

4DMedical (ASX:4DX) lands TGA approval and Australia's 74-scanner-per-million density now goes to work - Stocks Down Under

4DMedical (ASX:4DX) lands TGA approval and Australia's 74-scanner-per-million density now goes to work  Stocks Down Under

Stockhead

Neutral

just now

Emyria flags broader TGA therapy workforce scope

Emyria notes updated Therapeutic Goods Administration recommendations for psychedelic-assisted psychotherapy under the Authorised Prescriber scheme. ... Read More The post Emyria flags broader TGA therapy workforce scope appeared first on Stockhead.

Small Caps

Neutral

just now

Emyria Poised for Operational Boost as TGA Broadens Psych-Therapy Prescriber Access

Small Caps

Neutral

just now

OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device

Kalkine

Neutral

just now

TGA Nod Fuels Next Step in CAR-T Myeloma Study

Highlights TGA clearance opens path for first human trial CAR-T approach targets myeloma cells with precision Dual pipeline advances with antibody program A biotechnology company has secured regulatory approval to begin its first human study in multiple myeloma, while also progressing a second therapy program, marking a significant step toward clinical and commercial readiness. A Milestone in Multiple Myeloma Research Progress in multiple myeloma treatment continues to gain attention ac...